These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 17667947
1. Biodistribution and tumor infectivity of semliki forest virus vectors in mice: effects of re-administration. Rodriguez-Madoz JR, Prieto J, Smerdou C. Mol Ther; 2007 Dec; 15(12):2164-71. PubMed ID: 17667947 [Abstract] [Full Text] [Related]
6. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models. Määttä AM, Liimatainen T, Wahlfors T, Wirth T, Vähä-Koskela M, Jansson L, Valonen P, Häkkinen K, Rautsi O, Pellinen R, Mäkinen K, Hakumäki J, Hinkkanen A, Wahlfors J. Int J Cancer; 2007 Aug 15; 121(4):863-70. PubMed ID: 17443493 [Abstract] [Full Text] [Related]
8. Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF. Klimp AH, van der Vaart E, Lansink PO, Withoff S, de Vries EG, Scherphof GL, Wilschut J, Daemen T. Gene Ther; 2001 Feb 15; 8(4):300-7. PubMed ID: 11313804 [Abstract] [Full Text] [Related]
9. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. Kramer MG, Masner M, Casales E, Moreno M, Smerdou C, Chabalgoity JA. BMC Cancer; 2015 Sep 07; 15():620. PubMed ID: 26347489 [Abstract] [Full Text] [Related]
10. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer. Riezebos-Brilman A, Walczak M, Regts J, Rots MG, Kamps G, Dontje B, Haisma HY, Wilschut J, Daemen T. Gene Ther; 2007 Dec 07; 14(24):1695-704. PubMed ID: 17928874 [Abstract] [Full Text] [Related]
16. Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade. Quetglas JI, Labiano S, Aznar MÁ, Bolaños E, Azpilikueta A, Rodriguez I, Casales E, Sánchez-Paulete AR, Segura V, Smerdou C, Melero I. Cancer Immunol Res; 2015 May 07; 3(5):449-54. PubMed ID: 25691326 [Abstract] [Full Text] [Related]